Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia

Nature Medicine 23, 472 (2017).
doi:10.1038/nm.4310

Authors: Meenu Kesarwani, Zachary Kincaid, Ahmed Gomaa, Erika Huber, Sara Rohrabaugh, Zain Siddiqui, Muhammad F Bouso, Tahir Latif, Ming Xu, Kakajan Komurov, James C Mulloy, Jose A Cancelas, H Leighton Grimes & Mohammad Azam

Source: Nature Medicine - March 20, 2017 Category: Journals (General) Authors: Meenu Kesarwani Zachary Kincaid Ahmed Gomaa Erika Huber Sara Rohrabaugh Zain Siddiqui Muhammad F Bouso Tahir Latif Ming Xu Kakajan Komurov James C Mulloy Jose A Cancelas H Leighton Grimes Mohammad Azam Tags: Article Source Type: research